Guselkumab, Risankizumab, and Tildrakizumab in the Management of Hidradenitis Suppurativa: A Review of Existing Trials and Real-Life Data

Autor: Martora F, Scalvenzi M, Battista T, Fornaro L, Potestio L, Ruggiero A, Megna M

Publikováno v: Clinical, Cosmetic and Investigational Dermatology, Vol Volume 16, Pp 2525-2536 (2023)

Fabrizio Martora, Massimiliano Scalvenzi, Teresa Battista, Luigi Fornaro, Luca Potestio, Angelo Ruggiero, Matteo Megna Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, ItalyCorrespondence:

Externí odkaz: https://doaj.org/article/da30fb890f9c4a88a3277c544bdb9c20

Biologics for the Management of Erythrodermic Psoriasis: An Updated Review

Autor: Potestio L, Camela E, Cacciapuoti S, Fornaro L, Ruggiero A, Martora F, Battista T, Megna M

Publikováno v: Clinical, Cosmetic and Investigational Dermatology, Vol Volume 16, Pp 2045-2059 (2023)

Luca Potestio,1 Elisa Camela,2 Sara Cacciapuoti,1 Luigi Fornaro,1 Angelo Ruggiero,1 Fabrizio Martora,1 Teresa Battista,1 Matteo Megna1 1Section of Dermatology, Department of Clinical Medicine and Surgery, University of Naples Federico II, Naples, Ita

Externí odkaz: https://doaj.org/article/2ae5301db5bd4448aa22d5b81c3f1c70

Distribution of ²¹⁰ Po in the trophic levels of a brackish lagoon in Uruguay.

Autor: Bañobre C; Centro Universitario Regional del Este, Universidad de la República, 27000, Rocha, Uruguay. cbanobre@cure.edu.uy., Díaz-Francés I; Grupo Física Nuclear Aplicada, Universidad de Sevilla, 41012, Seville, Spain., Fornaro L; Centro Universitario Regional del Este, Universidad de la República, 27000, Rocha, Uruguay., García-Tenorio R; Grupo Física Nuclear Aplicada, Universidad de Sevilla, 41012, Seville, Spain.; Centro Nacional de Aceleradores, (Universidad de Sevilla-Junta de Andalucía-CSIC), 41092, Seville, Spain.

Publikováno v: Environmental science and pollution research international [Environ Sci Pollut Res Int] 2024 Nov 14. Date of Electronic Publication: 2024 Nov 14.

Durvalumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in Biliary Tract Cancer: a Real-World Retrospective, Multicenter Study.

Autor: Rimini M; Department of Oncology, IRCCS San Raffaele Scientific Institute Hospital, Vita-Salute San Raffaele University, Milan, Italy., Masi G; Division of Medical Oncology, Department of Translational Research and New Technologies in Medicine and Surgery, Pisa University Hospital, Pisa, Italy., Lonardi S; Dept of Oncology, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy., Nichetti F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, ENETS Center of Excellence, Via Venezian 1, 20133, Milan, Italy.; Computational Oncology, Molecular Diagnostics Program, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany., Pressiani T; Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy., Lavacchi D; Clinical Oncology Unit, Careggi University Hospital, 50134, Florence, Italy., Jessica L; Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200, 00128, Roma, Italy., Giordano G; Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy., Scartozzi M; Medical Oncology, University and University Hospital, Cagliari, Italy., Tamburini E; Department of Oncology and Palliative Care, Cardinale G Panico, Tricase City Hospital, Tricase, Italy., Pastorino A; Medical Oncology Unit 1, Ospedale Policlinico San Martino, IRCCS, Genoa, Italy., Rapposelli IG; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy., Daniele B; Medical Oncology Unit, Ospedale del Mare, Napoli, Italy., Martinelli E; Medical Oncology Unit, Department of Precision Medicine, Università Degli Studi Della Campania 'Luigi Vanvitelli', Naples, Italy., Garajova I; Medical Oncology Unit, University Hospital of Parma, Parma, Italy., Aprile G; Department of Oncology, San Bortolo General Hospital, Vicenza, Italy., Schirripa M; Medical Oncology Unit, Department of Oncology and Hematology, Belcolle Hospital, Viterbo, Italy., Formica V; Medical Oncology Unit, Department of Systems Medicine, Tor Vergata University Hospital, Rome, Italy., Salani F; Division of Medical Oncology, Department of Translational Research and New Technologies in Medicine and Surgery, Pisa University Hospital, Pisa, Italy., Winchler C; Clinical Oncology Unit, Careggi University Hospital, 50134, Florence, Italy., Bergamo F; Dept of Oncology, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy., Balsano R; Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.; Medical Oncology Unit, Department of Systems Medicine, Tor Vergata University Hospital, Rome, Italy., Gusmaroli E; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, ENETS Center of Excellence, Via Venezian 1, 20133, Milan, Italy., Lorenzo A; Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200, 00128, Roma, Italy., Landriscina M; Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy., Pretta A; Medical Oncology, University and University Hospital, Cagliari, Italy., Toma I; Department of Oncology and Palliative Care, Cardinale G Panico, Tricase City Hospital, Tricase, Italy., Pirrone C; Medical Oncology Unit 1, Ospedale Policlinico San Martino, IRCCS, Genoa, Italy., Diana A; Medical Oncology Unit, Ospedale del Mare, Napoli, Italy., Leone F; Division of Medical Oncology, ASL BI, Nuovo Ospedale degli Infermi, Ponderano, BI, Italy., Brunetti O; Istituto Tumori 'Giovanni Paolo II' of Bari, IRCCS, Bari, Italy., Brandi G; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138, Bologna, Italy., Garattini SK; Department of Oncology, Academic Hospital of Udine ASUFC, Piazzale Santa Maria della Misericordia 15, 33100, Udine, UD, Italy., Satolli MA; Division of Medical Oncology 1, Centro Oncologico Ematologico Subalpino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy., Rossari F; Department of Oncology, IRCCS San Raffaele Scientific Institute Hospital, Vita-Salute San Raffaele University, Milan, Italy., Fornaro L; Division of Medical Oncology, Department of Translational Research and New Technologies in Medicine and Surgery, Pisa University Hospital, Pisa, Italy., Niger M; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, ENETS Center of Excellence, Via Venezian 1, 20133, Milan, Italy., Zanuso V; Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy., De Rosa A; Dept of Oncology, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy.; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, ENETS Center of Excellence, Via Venezian 1, 20133, Milan, Italy.; Computational Oncology, Molecular Diagnostics Program, National Center for Tumor Diseases (NCT) and German Cancer Research Center (DKFZ), Heidelberg, Germany.; Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.; Clinical Oncology Unit, Careggi University Hospital, 50134, Florence, Italy.; Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200, 00128, Roma, Italy.; Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.; Medical Oncology, University and University Hospital, Cagliari, Italy.; Department of Oncology and Palliative Care, Cardinale G Panico, Tricase City Hospital, Tricase, Italy.; Medical Oncology Unit 1, Ospedale Policlinico San Martino, IRCCS, Genoa, Italy.; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Medical Oncology Unit, Ospedale del Mare, Napoli, Italy.; Medical Oncology Unit, Department of Precision Medicine, Università Degli Studi Della Campania 'Luigi Vanvitelli', Naples, Italy.; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.; Department of Oncology, San Bortolo General Hospital, Vicenza, Italy.; Medical Oncology Unit, Department of Oncology and Hematology, Belcolle Hospital, Viterbo, Italy.; Medical Oncology Unit, Department of Systems Medicine, Tor Vergata University Hospital, Rome, Italy.; Division of Medical Oncology, ASL BI, Nuovo Ospedale degli Infermi, Ponderano, BI, Italy.; Istituto Tumori 'Giovanni Paolo II' of Bari, IRCCS, Bari, Italy.; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138, Bologna, Italy.; Department of Oncology, Academic Hospital of Udine ASUFC, Piazzale Santa Maria della Misericordia 15, 33100, Udine, UD, Italy.; Division of Medical Oncology 1, Centro Oncologico Ematologico Subalpino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.; Department of Surgery, oncology and gastroenterology of Padua, Padua, Italy., Ratti F; Hepatobiliary Surgery Division, IRCCS Ospedale San Raffaele, Milan, Italy., Aldrighetti L; Vita-Salute San Raffaele University, Milan, Italy., De Braud F; Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, ENETS Center of Excellence, Via Venezian 1, 20133, Milan, Italy.; Clinical Oncology Unit, Careggi University Hospital, 50134, Florence, Italy.; Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200, 00128, Roma, Italy.; Department of Medical and Surgical Sciences, University of Foggia, Foggia, Italy.; Medical Oncology, University and University Hospital, Cagliari, Italy.; Department of Oncology and Palliative Care, Cardinale G Panico, Tricase City Hospital, Tricase, Italy.; Medical Oncology Unit 1, Ospedale Policlinico San Martino, IRCCS, Genoa, Italy.; Department of Medical Oncology, IRCCS Istituto Romagnolo per lo Studio dei Tumori (IRST) 'Dino Amadori', Meldola, Italy.; Medical Oncology Unit, Ospedale del Mare, Napoli, Italy.; Medical Oncology Unit, Department of Precision Medicine, Università Degli Studi Della Campania 'Luigi Vanvitelli', Naples, Italy.; Medical Oncology Unit, University Hospital of Parma, Parma, Italy.; Department of Oncology, San Bortolo General Hospital, Vicenza, Italy.; Medical Oncology Unit, Department of Oncology and Hematology, Belcolle Hospital, Viterbo, Italy.; Medical Oncology Unit, Department of Systems Medicine, Tor Vergata University Hospital, Rome, Italy.; Division of Medical Oncology, ASL BI, Nuovo Ospedale degli Infermi, Ponderano, BI, Italy.; Istituto Tumori 'Giovanni Paolo II' of Bari, IRCCS, Bari, Italy.; Medical Oncology, IRCCS Azienda Ospedaliero-Universitaria di Bologna, 40138, Bologna, Italy.; Department of Oncology, Academic Hospital of Udine ASUFC, Piazzale Santa Maria della Misericordia 15, 33100, Udine, UD, Italy.; Division of Medical Oncology 1, Centro Oncologico Ematologico Subalpino, Azienda Ospedaliero-Universitaria Città della Salute e della Scienza di Torino, Torino, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy.; Department of Surgery, oncology and gastroenterology of Padua, Padua, Italy.; Hepatobiliary Surgery Division, IRCCS Ospedale San Raffaele, Milan, Italy.; Vita-Salute San Raffaele University, Milan, Italy.; Department of Oncology and Hemato-Oncology, University of Milan, Milan, Italy., Foti S; Department of Oncology, IRCCS San Raffaele Scientific Institute Hospital, Vita-Salute San Raffaele University, Milan, Italy., Rizzato MD; Dept of Oncology, Veneto Institute of Oncology IOV-IRCCS, Padova, Italy., Vivaldi C; Division of Medical Oncology, Department of Translational Research and New Technologies in Medicine and Surgery, Pisa University Hospital, Pisa, Italy., Stefano C; Department of Oncology, IRCCS San Raffaele Scientific Institute Hospital, Vita-Salute San Raffaele University, Milan, Italy., Rimassa L; Medical Oncology and Hematology Unit, IRCCS Humanitas Research Hospital, Rozzano, Milan, Italy.; Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy., Antonuzzo L; Clinical Oncology Unit, Careggi University Hospital, 50134, Florence, Italy., Casadei-Gardini A; Department of Oncology, IRCCS San Raffaele Scientific Institute Hospital, Vita-Salute San Raffaele University, Milan, Italy. casadeigardini@gmail.com.; Department of Medical Oncology, IRCCS San Raffaele Hospital, Via Olgettina n. 60, Milan, Italy. casadeigardini@gmail.com.

Publikováno v: Targeted oncology [Target Oncol] 2024 May; Vol. 19 (3), pp. 359-370. Date of Electronic Publication: 2024 May 01.

Ramucirumab plus paclitaxel as switch maintenance versus continuation of first-line oxaliplatin-based chemotherapy in patients with advanced HER2-negative gastric or gastro-oesophageal junction cancer (ARMANI): a randomised, open-label, multicentre, phase 3 trial.

Autor: Randon G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Lonardi S; Department of Oncology, Veneto Institute of Oncology Istituto Oncologico Veneto-IRCCS, Padua, Italy., Fassan M; Surgical Pathology Unit, Department of Medicine, University Hospital of Padua, Padua, Italy; Veneto Institute of Oncology IOV-IRCCS, Padua, Italy., Palermo F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Tamberi S; Oncology Unit, Santa Maria delle Croci Hospital, Azienda Unità Sanitaria Locale della Romagna, Ravenna, Italy., Giommoni E; Medical Oncology Unit, Careggi University Hospital, Florence, Italy., Ceccon C; Surgical Pathology Unit, Department of Medicine, University Hospital of Padua, Padua, Italy., Di Donato S; Medical Oncology Department ASL Toscana Centro, Santo Stefano Hospital, Prato, Italy., Fornaro L; Unit of Medical Oncology, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy., Brunetti O; Istituto Tumori 'Giovanni Paolo II' of Bari IRCCS, Bari, Italy., De Vita F; Division of Medical Oncology, Department of Precision Medicine, University of Campania 'L Vanvitelli', Naples, Italy., Bittoni A; Oncology Unit, Istituto Romagnolo Per Lo Studio Dei Tumori 'Dino Amadori' IRCCS, Meldola, Italy., Chini C; Department of Medical Oncology, ASST Sette Laghi, Ospedale di Circolo e Fondazione Macchi, Varese, Italy., Spallanzani A; Department of Oncology and Haematology, Division of Oncology, University Hospital of Modena, Modena, Italy., Nappo F; Department of Oncology, Veneto Institute of Oncology Istituto Oncologico Veneto-IRCCS, Padua, Italy., Bethaz V; Department of Oncology, 'San Luigi Gonzaga' University Hospital, University of Turin, Orbassano, Italy., Strippoli A; Comprehensive Cancer Center, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Università Cattolica del Sacro Cuore, Rome, Italy., Latiano T; Department of Oncology, Fondazione IRCCS 'Casa Sollievo della Sofferenza' Hospital, San Giovanni Rotondo, Foggia, Italy., Cardellino GG; Department of Oncology, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy., Giuliani F; Istituto Tumori 'Giovanni Paolo II' of Bari IRCCS, Bari, Italy; Medical Oncology Unit, San Paolo Hospital, Bari, Italy., Morano F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Niger M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Raimondi A; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Prisciandaro M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Pircher CC; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Sciortino C; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Marchesi S; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Garattini SK; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Oncology, Azienda Sanitaria Universitaria Friuli Centrale, Udine, Italy., Airò G; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy; Department of Medicine and Surgery, University of Parma, Parma, Italy., Miceli R; Unit of Biostatistics for Clinical Research, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Di Bartolomeo M; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy., Pietrantonio F; Medical Oncology Department, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, Italy. Electronic address: filippo.pietrantonio@istitutotumori.mi.it.

Publikováno v: The Lancet. Oncology [Lancet Oncol] 2024 Nov 15. Date of Electronic Publication: 2024 Nov 15.